Is the pharmaceutical sector prepared to face a titanium dioxide ban?
Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules
In the wake of the ban on titanium dioxide (TiO2) E171 in the production of food and dietary supplements in the EU, the pharmaceutical industry may face a similar ban as early as 2025.